Endothelin receptor antagonists

Papers on endothelin receptor antagonists

17 papers6 new in 30 days

Thursday, November 12

BiomoleculesNov 12

Endothelin-1 and the Fibrinolytic System in Obesity: A Mechanistic Account of Hypofibrinolysis and Cardiometabolic Risk

ReviewMechanisms

Friday, October 30

Clinical Kidney JournalOct 30

Endothelin antagonism: a new era for resistant hypertension

Definition of resistant hypertension.

ReviewEndothelin receptor antagonists

Thursday, October 29

BMC NephrologyOct 29

Therapeutic landscape of Alport syndrome: current standard of care and ongoing clinical trials

Figure from BMC Nephrology

ReviewInterventions

Glomerular DiseasesOct 29

Combination Kidney-Protective Therapy in Diabetic Kidney Disease: From RAAS Blockade to Multidrug Precision Nephrology

ReviewDiabetic kidney disease

Frontiers in MedicineOct 29

Treatment and practical considerations of IgA nephropathy

Visual representation of the pathophysiology of IgA nephropathy and the 4-Hit hypothesis.

ReviewIgA nephropathy

Tuesday, October 27

Human ImmunologyOct 27

IgA nephropathy: evolving pathogenic concepts and emerging targeted therapies

Figure from Human Immunology

ReviewIgA nephropathy

Saturday, August 29

Biochemical PharmacologyAug 29

Drug failure in diabetic kidney disease: translational barriers, target validation and trial de-risking strategies

Figure from Biochemical Pharmacology

ReviewDiabetic kidney disease

Sunday, March 29

Clinical MedicineMar 29

Obstructive sleep apnoea and hypertension: Current understanding, diagnosis and management

ReviewResistant hypertension

Tuesday, March 17

BMC NephrologyMar 17

Efficacy and safety of supportive and immunosuppressive therapies in the treatment of lgA nephropathy: a network Meta-analysis of randomized clinical trials

Meta-analysis of randomized trialsIgA nephropathy

Saturday, February 28

Seminars in NephrologyFeb 28

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies

ReviewChronic kidney disease

Monday, February 9

Reviews in Cardiovascular MedicineFeb 9

Resistant Hypertension: Integration of Novel Agents and Interventional Approaches in Clinical Practice

ReviewResistant hypertension

Tuesday, January 13

Nature Reviews NephrologyJan 13

Next-generation therapeutics for diabetic kidney disease

ReviewDiabetic kidney disease

Sunday, November 23

Journal of Clinical MedicineNov 23

Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed

ReviewChronic kidney disease

Friday, January 24

Frontiers in PharmacologyJan 24

Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)

ReviewEndothelin receptor antagonists

Tuesday, January 23

LifeJan 23

Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction-An Updated Review of the Literature

ReviewMechanisms

Wednesday, October 18

PLOS OneOct 18

A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial

Case-control study in peopleAlzheimer's disease and related dementias

Saturday, November 5

Brain CommunicationsNov 5

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study

Cohort study in peopleAlzheimer's disease